Establishment Labs Inc.

31.28
-2.58 (-7.62%)
At close: Apr 04, 2025, 2:43 PM

Company Description

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery.

The company primarily offers silicone gel-filled breast implants under Motiva Implants brand name.

It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander, as well as distributes Puregraft line of products for autologous adipose tissue harvesting and redistribution.

The company sells its products through exclusive distributors and direct sales force in Europe, Latin America, the Asia-Pacific, and internationally.

Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.

Establishment Labs Inc.
Establishment Labs  Inc. logo
Country CR
IPO Date Jul 19, 2018
Industry Medical - Devices
Sector Healthcare
Employees 1,018
CEO Filippo Caldini

Contact Details

Address:
Building B15 and 25
Alajuela,
CR
Website https://www.establishmentlabs.com

Stock Details

Ticker Symbol ESTA
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001688757
CUSIP Number G31249108
ISIN Number VGG312491084
Employer ID 98-1436377
SIC Code 3842

Key Executives

Name Position
Filippo Caldini Interim Chief Executive Officer & President
Rajbir Singh Denhoy Chief Financial Officer
Roberto de Mezerville Chief Technology Officer
Ivan Bilic Senior Vice President of Commercial Operations - OUS
Jeff Ehrhardt Senior Vice President & GM of North America
Juan Jose Chacon Quiros Founder & Executive Director
Neeta Toprani Corporate Secretary
Rosalyn Cole d'Incelli SVice President of Global Clinical, Medical & US Regulatory Affairs
S. Ross Mansbach General Counsel, Chief Compliance Officer & Chief Human Resources Officer
Salvador Santos Dada Head of Special Projects

Latest SEC Filings

Date Type Title
Apr 01, 2025 4 Filing
Apr 01, 2025 4 Filing
Apr 01, 2025 4 Filing
Apr 01, 2025 4 Filing
Apr 01, 2025 4 Filing
Mar 26, 2025 4 Filing
Mar 20, 2025 4 Filing
Mar 20, 2025 4 Filing
Mar 20, 2025 4 Filing
Feb 28, 2025 S-8 Filing